| Source | Code | Name | Case count | Share of cases (%) |
|---|---|---|---|---|
| PURCH | PURCH_ATC(L04AB04) | Adalimumab | 2013 | |
| PURCH | PURCH_ATC(L04AB01) | Etanercept | 1595 | |
| PURCH | PURCH_ATC(L04AB06) | Golimumab | 802 | |
| PURCH | PURCH_ATC(L04AB05) | Certolizumab pegol | 397 | |
| PURCH | PURCH_ATC(L04AA24) | Abatacept | 324 | |
| PURCH | PURCH_ATC(L04AC10) | Secukinumab | 313 | |
| PURCH | PURCH_ATC(L04AC05) | Ustekinumab | 269 | |
| PURCH | PURCH_ATC(L04AC07) | Tocilizumab | 202 | |
| PURCH | PURCH_ATC(L04AC03) | Anakinra | 31 |